Clinical Trial Update: A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial by Astellas evaluating pre-emptive treatment for invasive candidiasis in high-risk surgical subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Mycoses | Phase 2 | Status: COMPLETED